| 1 |
35199421 | Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial. | 2022 May |
1 |
| 2 |
31957468 | Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository Study. | 2020 Jan |
1 |
| 3 |
30921200 | Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials. | 2019 Mar |
1 |
| 4 |
29862486 | Determinants of the beneficial effect of mineralocorticoid receptor antagonism on exercise capacity in heart failure with reduced ejection fraction. | 2018 |
1 |
| 5 |
28202884 | Neurohumoral Modulation During Waon Therapy in Chronic Heart Failure　- Subanalysis of Waon-CHF Study. | 2017 Apr 25 |
1 |
| 6 |
25993594 | Influence of spironolactone on matrix metalloproteinase-2 in acute decompensated heart failure. | 2015 Apr |
1 |
| 7 |
17126073 | Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. | 2007 Apr |
1 |
| 8 |
16700881 | Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor. | 2006 May-Jun |
2 |
| 9 |
17168346 | The role of BNP testing in heart failure. | 2006 Dec 1 |
2 |
| 10 |
15932659 | [Effect of spironolactone on left ventricular remodeling in patients with acute myocardial infarction]. | 2005 Apr |
2 |
| 11 |
16130189 | Brain natriuretic peptide and optimal management of heart failure. | 2005 Sep |
1 |
| 12 |
15201246 | Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment. | 2004 Jul |
1 |
| 13 |
15912436 | [Natriuretic peptides--new diagnostic markers in heart disease]. | 2004 Sep |
1 |
| 14 |
12942029 | Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure. | 2003 Aug |
4 |
| 15 |
11300427 | Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. | 2001 Apr |
3 |